Real World Effectiveness, Safety and Pharmacokinetics of Switching Intravenous Vedolizumab Maintenance treatment to Subcutaneous Vedolizumab Therapy for Inflammatory Bowel Disease

被引：0
|
作者：
Volkers, A. [1 ]
Straatmijer, T. [1 ]
Duijvestein, M. [2 ]
Sales, A. [1 ]
Levran, A. [1 ]
van Schaik, F. [3 ]
Jeroen, M. [4 ]
Gecse, K. [1 ]
Ponsioen, C. [1 ]
Grootjans, J. [1 ]
Hanzel, J. [1 ]
Tack, G. [5 ]
Jansen, J. [6 ]
Hoentjen, F. [7 ]
de Boer, N. [1 ]
van der Marel, S. [8 ]
Dijkstra, G. [9 ]
Oldenburg, B. [3 ]
Lowenberg, M. [1 ]
van der Meulen, A. [4 ]
D'Haens, G. [1 ]
机构：
[1] Amsterdam UMC, Locat AMC, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, Nijmegen, Netherlands
[3] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands
[4] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
[5] Med Ctr Leeuwarden, Dept Gastroenterol & Hepatol, Leeuwarden, Netherlands
[6] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[7] Univ Alberta, Dept Med, Div Gastroenterol, Edmonton, AB, Canada
[8] Haaglanden Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands
[9] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP63
引用
收藏
页码：I108 / I109
页数：3
相关论文
共 50 条
  • [21] Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience
    Fric, Vlasta Orsic
    Borzan, Vladimir
    Sahinovic, Ines
    Borzan, Andrej
    Kurbel, Sven
    PHARMACEUTICALS, 2023, 16 (02)
  • [22] Real-world experiences of switching to subcutaneous formulation in IBD patients on maintenance vedolizumab treatment
    Bacsur, P.
    Resal, T.
    Farkas, B.
    Sarlos, P.
    Ilias, A.
    Kata, D.
    Balint, A.
    Fabian, A.
    Bor, R.
    Szepes, Z.
    Molnar, T.
    Farkas, K.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1269 - I1270
  • [23] REAL WORLD EXPERIENCE OF THE TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS FORMULATION OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: CURRENT DATA REVIEW
    Robertson, James
    Kamble, Pravin
    Agboton, Christian
    GUT, 2023, 72 (SUPPL_2) : A108 - A108
  • [24] Real world experience of the transition from the intravenous to subcutaneous formulation of vedolizumab in inflammatory bowel disease: A review of current data
    Agboton, C.
    Kamble, P.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 835 - 836
  • [25] Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Whitney, Annette
    Sarles, Harry E., Jr.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S396 - S396
  • [26] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    GASTROENTEROLOGY, 2018, 154 (01) : S82 - S82
  • [27] Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]
    Ventress, Esther
    Young, David
    Rahmany, Sohail
    Harris, Clare
    Bettey, Marion
    Smith, Trevor
    Moyses, Helen
    Lech, Magdalena
    Gwiggner, Markus
    Felwick, Richard
    Cummings, J. R. Fraser
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (06): : 911 - 921
  • [28] Safety of Vedolizumab in Inflammatory Bowel Disease in a Multi-Center Real World Consortium
    Chaudrey, Khadija
    Whitehead, Diana
    Dulai, Parambir S.
    Peerani, Farhad
    Narula, Neeraj
    Hudesman, David
    Shmidt, Eugenia
    Lukin, Dana J.
    Swaminath, Arun
    Nghia Nguyen
    Meserve, Joseph
    Singh, Siddharth
    Boland, Brigid S.
    Sandborn, William
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Kane, Sunanda V.
    Loftus, Edward V.
    Siegel, Corey A.
    GASTROENTEROLOGY, 2016, 150 (04) : S974 - S974
  • [29] Effectiveness of Switching to Subcutaneous Infliximab in Pediatric Inflammatory Bowel Disease Patients on Intravenous Maintenance Therapy
    Gianolio, Laura
    Armstrong, Katherine
    Swann, Ewan
    Shepherd, Rhona
    Henderson, Paul
    Wilson, David C. C.
    Russell, Richard K. K.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2023, 77 (02): : 235 - 239
  • [30] REAL-WORLD SAFETY OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A META-ANALYSIS
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Mosli, Mahmoud
    Hather, Greg
    Demuth, Dirk
    Blake, Aimee
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward V., Jr.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 : S57 - S58
12345